•Matricelf (TASE: MTLF) announced a strategic collaboration with Sheba Medical Center to support its first-in-human clinical trial for spinal cord injury.
•Sheba Medical Center is ranked 7th globally by Newsweek.
•The program focuses on developing autologous engineered neural tissue therapies in the field of regenerative medicine.
•Apollo-managed funds announced an agreement to acquire Nippon Sheet Glass (NSG) for an enterprise value of approximately $3.7 billion (JPY 590 billion).
•The transaction marks Apollo's largest private equity investment in Japan to date.
•NSG is a global leader in glass manufacturing for architectural, automotive, and solar sectors.